Possible Associations of NTRK2 Polymorphisms with Antidepressant Treatment Outcome: Findings from an Extended Tag SNP Approach

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hennings, Johannes M ^a   Kohli, Martin A ^a,g   Czamara, Darina ^a,b   Giese, Maria ^c   Eckert, Anne ^c   Wolf, Christiane ^a   Heck, Angela ^a,h   Domschke, Katharina ^d   Arolt, Volker ^e   Baune, Bernhard T ^f   Horstmann, Sonja ^a   Brückl, Tanja ^a   Klengel, Torsten ^a   Menke, Andreas ^a   Müller Myhsok, Bertram ^a,b   Ising, Marcus ^a   Uhr, Manfred ^a   Lucae, Susanne ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b Germany 3 Munich Cluster for Systems Neurology   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR;

ADULT; ARTICLE; BDNF GENE; BIPOLAR DEPRESSION; CAUCASIAN; CONTROLLED STUDY; DEPRESSION; DRUG RESPONSE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NTRK2 GENE; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; THERAPY RESISTANCE; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COMPUTATIONAL BIOLOGY; FEMALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, TRKB; REPRODUCIBILITY OF RESULTS; SEX CHARACTERISTICS; TREATMENT OUTCOME;

ANIMALIA;

EID: 84878653433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064947     Document Type: Article

References (67)

1. Hennings JM, Owashi T, Binder EB, Horstmann S, Menke A, et al. (2009) Clinical characteristics and treatment outcome in a representative sample of depressed inpatients- findings from the Munich Antidepressant Response Signature (MARS) project. J Psychiatr Res 43: 215-229.
2. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, et al. (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163: 1905-1917.
3. Holsboer F, (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23: 477-501.
4. Duman RS, Monteggia LM, (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127.
5. Groves JO, (2007) Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12: 1079-1088.
6. Schaaf MJ, de Jong J, de Kloet ER, Vreugdenhil E, (1998) Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res 813: 112-120.
7. Smith MA, Makino S, Kvetnansky R, Post RM, (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15: 1768-1777.
8. Poo MM, (2001) Neurotrophins as synaptic modulators. Nat Rev Neurosci 2: 24-32.
9. Kozisek ME, Middlemas D, Bylund DB, (2008) Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther 117: 30-51.
10. Sillaber I, Panhuysen M, Henniger MSH, Ohl F, Kühne C, et al. (2008) Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology (Berl) 200: 557-572.
11. Dwivedi Y, (2009) Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat 5: 433-449.
12. Knapman A, Heinzmann J-M, Hellweg R, Holsboer F, Landgraf R, et al. (2010) Increased stress reactivity is associated with cognitive deficits and decreased hippocampal brain-derived neurotrophic factor in a mouse model of affective disorders. J Psychiatr Res 44: 566-575.
13. Tadić A, Wagner S, Schlicht KF, Peetz D, Borysenko L, et al. (2011) The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 35: 415-420.
14. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, et al. (2003) Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23: 349-357.
15. Nibuya M, Morinobu S, Duman RS, (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15: 7539-7547.
16. Rantamäki T, Knuuttila JEA, Hokkanen M-E, Castrén E, (2006) The effects of acute and long-term lithium treatments on trkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex. Neuropharmacology 50: 421-427.
17. Rantamäki T, Hendolin P, Kankaanpää A, Mijatovic J, Piepponen P, et al. (2007) Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 32: 2152-2162.
18. Kato M, Serretti A (2008) Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry. Available: http://www.ncbi.nlm.nih.gov/pubmed/18982004. Accessed 2009 Sep 15.
19. Zou Y-F, Wang Y, Liu P, Feng X-L, Wang B-Y, et al. (2010) Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology 61: 71-78.
20. Petryshen TL, Sabeti PC, Aldinger KA, Fry B, Fan JB, et al. (2010) Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Mol Psychiatry 15: 810-815.
21. Dong C, Wong M-L, Licinio J, (2009) Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Mol Psychiatry 14: 1105-1118.
22. Licinio J, Dong C, Wong M-L, (2009) Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Arch Gen Psychiatry 66: 488-497.
23. Domschke K, Lawford B, Laje G, Berger K, Young R, et al. (2009) Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response. Int J Neuropsychopharmacol: 1-9.
24. McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, et al. (2006) Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 78: 804-814.
25. Baune BT, Hohoff C, Berger K, Neumann A, Mortensen S, et al. (2008) Association of the COMT val158 met variant with antidepressant treatment response in major depression. Neuropsychopharmacology 33: 924-932.
26. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, et al. (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36: 1319-1325.
27. Horstmann S, Dose T, Lucae S, Kloiber S, Menke A, et al. (2009) Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action. Psychoneuroendocrinology 34: 238-248.
28. Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, et al. (2007) Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression- a potential biomarker? Biol Psychiatry 62: 47-54 doi:10.1016/j.biopsych.2006.07.039.
29. Ising M, Lucae S, Binder EB, Bettecken T, Uhr M, et al. (2009) A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Arch Gen Psychiatry 66: 966-975.
30. Uhr M, Tontsch A, Namendorf C, Ripke S, Lucae S, et al. (2008) Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron 57: 203-209.
31. Kohli MA, Salyakina D, Pfennig A, Lucae S, Horstmann S, et al. (2010) Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients. Arch Gen Psychiatry 67: 348-359.
32. Skol AD, Scott LJ, Abecasis GR, Boehnke M, (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38: 209-213.
33. Colhoun H, Mckeigue P, Smith G, (2003) Problems of reporting genetic associations with complex outcomes. The Lancet 361: 865-872.
34. Westfall P, Young S (1993) Resampling-Based Multiple Testing: Examples and Methods for P-Value Adjustment. New York, NY: John Wiley & Sons.
35. North BV, Curtis D, Sham PC, (2002) A Note on the Calculation of Empirical P Values from Monte Carlo Procedures. Am J Hum Genet 71: 439-441.
36. Armitage P, (1955) Tests for Linear Trends in Proportions and Frequencies. Biometrics 11: 375-386.
37. Fisher RA (1932) Statistical methods for research workers. 4th ed. London: Oliver & Boyd.
38. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
39. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
40. Adams JH, Wigg KG, King N, Burcescu I, Vetró A, et al. (2005) Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood-onset mood disorders. Am J Med Genet B Neuropsychiatr Genet 132B: 90-95.
41. Gratacòs M, Soria V, Urretavizcaya M, González JR, Crespo JM, et al. (2008) A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. Pharmacogenomics J 8: 101-112.
42. Kocabas NA, Antonijevic I, Faghel C, Forray C, Kasper S, et al. (2011) Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder. Int Clin Psychopharmacol 26: 1-10.
43. Stranger BE, Montgomery SB, Dimas AS, Parts L, Stegle O, et al. (2012) Patterns of Cis Regulatory Variation in Diverse Human Populations. PLoS Genet 8: e1002639.
44. Alonso P, Gratacòs M, Menchón JM, Saiz-Ruiz J, Segalàs C, et al. (2008) Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder. Biol Psychiatry 63: 619-628.
45. Cozza A, Melissari E, Iacopetti P, Mariotti V, Tedde A, et al. (2008) SNPs in neurotrophin system genes and Alzheimer's disease in an Italian population. J Alzheimers Dis 15: 61-70.
46. Perroud N, Aitchison KJ, Uher R, Smith R, Huezo-Diaz P, et al. (2009) Genetic Predictors of Increase in Suicidal Ideation During Antidepressant Treatment in the GENDEP Project. Neuropsychopharmacology. Available: http://www.ncbi.nlm.nih.gov/pubmed/19641488. Accessed 16 September 2009.
47. Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, et al. (2009) Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J 9: 225-233.
48. Lin E, Hong C-J, Hwang J-P, Liou Y-J, Yang C-H, et al. (2009) Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression. Rejuvenation Res 12: 387-393.
49. Dwivedi Y, Rizavi HS, Pandey GN, (2006) Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience 139: 1017-1029.
50. Choi M-J, Kang R-H, Lim S-W, Oh K-S, Lee M-S, (2006) Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res 1118: 176-182.
51. Kang R, Chang H, Wong M, Choi M, Park J, et al. (2009) Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression. J Psychopharmacol (Oxford). Available: http://www.ncbi.nlm.nih.gov/pubmed/19493959. Accessed 2009 Sep 14.
52. Tsai S-J, Hong C-J, Liou Y-J, (2008) Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics. Pharmacogenomics 9: 1353-1358.
53. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, et al. (2005) Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 58: 307-314.
54. Taylor WD, McQuoid DR, Ashley-Koch A, Macfall JR, Bridgers J, et al. (2010) BDNF Val66Met genotype and 6-month remission rates in late-life depression. Pharmacogenomics J. Available: http://www.ncbi.nlm.nih.gov/pubmed/20195291. Accessed 2011 Jan 25.
55. Wilkie MJV, Smith D, Reid IC, Day RK, Matthews K, et al. (2007) A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression. Pharmacogenet Genomics 17: 207-215.
56. Yoshida K, Higuchi H, Kamata M, Takahashi H, Inoue K, et al. (2007) The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine. J Psychopharmacol (Oxford) 21: 650-656.
57. Verhagen M, van der Meij A, van Deurzen PAM, Janzing JGE, Arias-Vásquez A, et al. (2010) Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 15: 260-271.
58. Hong C-J, Huo S-J, Yen F-C, Tung C-L, Pan G-M, et al. (2003) Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 48: 186-189.
59. Kunugi H, Iijima Y, Tatsumi M, Yoshida M, Hashimoto R, et al. (2004) No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol Psychiatry 56: 376-378.
60. Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, et al. (2003) Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 337: 17-20.
61. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, et al. (2002) The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71: 651-655.
62. Ghaemi SN, Ko JY, Goodwin FK, (2001) The bipolar spectrum and the antidepressant view of the world. J Psychiatr Pract 7: 287-297.
63. Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld RMA, (2008) Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord 10: 144-152.
64. Angst J, Sellaro R, Stassen HH, Gamma A, (2005) Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord 84: 149-157.
65. McMahon FJ, Akula N, Schulze TG, Muglia P, Tozzi F, et al. (2010) Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet 42: 128-131.
66. Baghai TC, Binder EB, Schule C, Salyakina D, Eser D, et al. (2006) Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry 11: 1003-1015.
67. Wittke-Thompson JK, Pluzhnikov A, Cox NJ, (2005) Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 76: 967-986.